Intervention Review

Drugs for treating giardiasis

  1. Joost Zaat1,*,
  2. T hG Mank2,
  3. W JJ Assendelft2

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 18 APR 2007

Assessed as up-to-date: 9 APR 1998

DOI: 10.1002/14651858.CD000217.pub2


How to Cite

Zaat J, Mank TH, Assendelft WJJ. Drugs for treating giardiasis. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD000217. DOI: 10.1002/14651858.CD000217.pub2.

Author Information

  1. 1

    Amsterdam, Netherlands

  2. 2

    Not specified

*Joost Zaat, Fluitekruid 13, 1441 XP Purmerend, Amsterdam, Netherlands. jzaat@knmg.nl.

Publication History

  1. Publication Status: Withdrawn from publication for reasons stated in the review
  2. Published Online: 18 APR 2007

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.

Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.